← All diseases
Liver, kidneys and digestion
Fatty liver disease (MASH/NASH), advanced
Do you want to receive a message when there is new research about Liver Fat (MASH/NASH), advanced? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research on Liver Steatosis (MASH/NASH), Advanced is available. View what Premium costs.
Publications and studies (2544)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Impact of the Mediterranean Diet, Physical Activity, and Nutrition Education on Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Review. (2025/12/20) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind. (2025/12/19) ♡
- Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Overweight and Obese Patients With Type 2 Diabetes Mellitus. (2025/12/19) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Guava (Psidium guajava L.) leaf extract improves the prognosis of nonalcoholic fatty liver and biochemical parameters in rats with metabolic syndrome. (2025/12/18) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Genistein ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and hepatic macrophage polarization. (2025/12/18) ♡
- NEDD4L knockdown reduced lipid accumulation in non-alcoholic fatty liver disease by promoting the activity of PI3K/AKT signaling pathway. (2025/12/18) ♡
- NUP85 siRNA loaded red blood cell-derived extracellular vesicles alleviate hepatic steatosis in MASLD. (2025/12/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. HCC in the Era of Emerging MASH: The Role of Ultrasound in Surveillance and New Sonographic Features in Diagnosis. (2025/12/18) ♡
- Oral Icariin Nanoparticles Ameliorate Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress. (2025/12/17) ♡
- Exploring Herbal and Indian Traditional Remedies in the Management of Non-Alcoholic Fatty Liver Disease: Recent Advances and Clinical Trial Insights. (2025/12/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metabolic Dysfunction-Associated Steatohepatitis With Positive Antimitochondrial M2 Antibodies: Diagnostic Pitfall and Importance of Follow-Up. (2025/12/16) ♡
- Quyu Huazhuo Decoction alleviates non-Alcoholic steatohepatitis via remodeling the gut microbiota and regulating bile acid and short-chain fatty acid metabolism. (2025/12/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ketogenic diets and metabolic dysfunction-associated steatotic liver disease: a literature review. (2025/12/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Circadian disruption aggravates non-alcoholic fatty liver disease by activating RIPK1-RIPK3-MLKL axis in mice. (2025/12/15) ♡
- Burden and trends of NASH-related liver cancer associated with high fasting plasma glucose in China and globally from 1990 to 2021: a population-based analysis of the global burden of disease study. (2025/12/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. European Bilberry Extract Ameliorates Dietary Advanced Glycation End Products-Induced Non-Alcoholic Steatohepatitis in Rats via Gut Microbiota and Its Metabolites. (2025/12/15) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. From fatty liver indices to the Zhejiang University index: Re-shaping risk stratification of metabolic liver disease in diabetes. (2025/12/15) ♡
- A set of downregulated pleiotropic genes are possible multi-omics biomarkers underlying the irritable bowel syndrome-non-alcoholic fatty liver disease comorbidity. (2025/12/15) ♡
- Tirzepatide alleviates non-alcoholic fatty liver disease by regulating lipid metabolism through activation of the AMPK/NF-κB signaling pathway. (2025/12/15) ♡
- Human umbilical cord-derived mesenchymal stem cells ameliorate non-alcoholic fatty liver disease via activating TFEB-mediated autophagy in male mice. (2025/12/13) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet). (2025/12/13) ♡
- Zearalenone exposure may increase the risk of non-alcoholic fatty liver disease by activating CYP1B1-SCD1. (2025/12/13) ♡
- Diet-induced RKIP downregulation disrupts PC/PE-ER homeostasis to drive MASLD. (2025/12/12) ♡
- The association between weight-adjusted waist index (WWI) and nonalcoholic fatty liver disease (NAFLD) in non-diabetic individuals: A study based on the NHANES database(2017-2023). (2025/12/12) ♡
- Fatty Acids as Nutritional Therapy for NAFLD: A Bibliometric Analysis of Research Trends and Future Directions. (2025/12/12) ♡
- Fraxin modulates lipid metabolism as well as gut flora to avert NAFLD. (2025/12/11) ♡
- Efficacy and safety of GLP-1 receptor agonists in MASH with fibrosis: A systematic review and meta-analysis. (2025/12/11) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Traditional Chinese medicine for non-alcoholic fatty liver disease: an overview of systematic reviews with evidence mapping and metabolic outcome assessment. (2025/12/10) ♡
- Maternal western-style diet alters Kupffer cell proportion leading to metabolic dysfunction-associated steatotic liver disease when challenged with western diet in adulthood. (2025/12/10) ♡
- A Multi-Omics Study Reveals the Active Components and Therapeutic Mechanism of Erhuang Quzhi Formula for Non-Alcoholic Fatty Liver Disease. (2025/12/10) ♡
- Impact of Polyphenol Supplementation on Energy Expenditure Measured by Indirect Calorimetry in Adolescents with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Randomized Study. (2025/12/08) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Qushi Huayu decoction alleviates NAFLD in mice by regulating gut microbiota homeostasis in the gut-liver axis via the pregnane X receptor. (2025/12/05) ♡
- Chaize mixture alleviates NAFLD by regulating Glipr2-related autophagy/NLRP3 signaling. (2025/12/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dual roles of T cells in metabolic dysfunction-associated steatohepatitis pathogenesis and liver fibrosis: From inflammation to therapeutic targets. (2025/12/03) ♡
- Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosis. (2025/12/02) ♡
- Quercetin alleviates metabolic-associated fatty liver disease by tuning hepatic lipid metabolism, oxidative stress and inflammation. (2025/12/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Kaili sour soup in alleviation of hepatic steatosis in rats via lycopene route: an experimental study. (2025/12/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Untargeted Metabolomic Study on the Mechanism of Polygonatum sibiricum in Non-Alcoholic Fatty Liver Disease in Rats Using UPLC-Q-TOF/MS. (2025/12/01) ♡
- Constituents-composed Chinese medicine of Dajianzhong Decoction ameliorates Non-alcoholic fatty liver disease via AMPK/PPARα/CPT1 signaling. (2025/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research advances in the diagnosis and treatment of MASLD/MASH. (2025/12/01) ♡
- MYD88 regulates the intercellular crosstalk landscape in MASH liver against metaflammation and metabolic disorder. (2025/12/01) ♡
- Unlocking the potential of atractylenolide II: Mitigating non-alcoholic fatty liver disease through farnesoid X receptor-endoplasmic reticulum stress interplay. (2025/12/01) ♡
- [Mechanism of Sini Power combined with Linggui Zhugan Decoction on NAFLD based on transcriptomics and metabolomics]. (2025/12/01) ♡
- Analysis of Fatty Liver Prevalence in Non-Obese Women Diagnosed with Polycystic Ovary Syndrome. (2025/12/01) ♡
- The Association Between Obesity Indices and Non-Alcoholic Fatty Liver Disease in Patients with Ankylosing Spondylitis. (2025/12/01) ♡
- Screening for non-alcoholic fatty liver disease (NAFLD) among adults in Puducherry, India: A community-based cross-sectional study. (2025/12/01) ♡
- Ginseng-derived exosome-like nanovesicles protect against liver fibrosis by regulating TIMP2 pathways and gut dysbiosis. (2025/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Potential pharmacotherapy pathways in metabolic dysfunction-associated steatotic liver disease. (2025/12/01) ♡
- Diagnosing and treating fatty liver disease: strategies for hepatocellular carcinoma and cardiovascular disease prevention. (2025/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MAM and LDL Receptor Class A Domain Containing 1 Deficiency Aggravates Hepatic Fibrosis in Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis. (2025/11/29) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.